Bicycle Therapeutics plc American Depositary Shares

BCYC XNAS PHARMACEUTICAL PREPARATIONS

Market Cap

300M

Short interest (May 15)

3.9%

Net Short (Jun 03 ): -0.1%

Borrow Fee

0.27%

↓ 25.2%

Available Shares

2M

↓ 5.9%

Price Chart

Company Overview

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Company Info

Exchange: NASDAQ
Industry: PHARMACEUTICAL PREPARATIONS
CIK: 0001761612
Asset Type: ADRC

Market Data

Market Cap: $300,188,267
Employees: 288
Status: Active

Short Interest

Current Borrow Fee 0.27%
Range: 0.27% - 0.27%
Available Shares 2M
Range: 2.1M - 2.2M

Recent Changes

Fee Change: ↓ 32.9%
Available Change: ↓ 2.3%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime